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Aims Estimates of the left ventricular ejection fraction (LVEF) in patients with life-threatening ventricular arrhythmias
related to coronary artery disease (CAD) have rarely been reported despite it has become the basis for determining
patient’s eligibility for prophylactic defibrillator. We aimed to determine the extent and distribution of reduced LVEF
in patients with sustained ventricular tachycardia or ventricular fibrillation.
Methods
and results
252 patients admitted for ventricular arrhythmia related to CAD were included: 149 had acute myocardial infarction
(MI) (Group I, 59%), 54 had significant chronic obstructive CAD suggestive of an ischaemic arrhythmic trigger (Group
II, 21%) and 49 patients had an old MI without residual ischaemia (Group III, 19%). 34% of the patients with scar-
related arrhythmias had an LVEF 40%. Based on pre-event LVEF evaluation, it can be estimated that less than
one quarter of the whole study population had a known chronic MI with severely reduced LVEF. In Group III, the
proportion of inferior MI was significantly higher than anterior MI (81 vs. 19%; absolute difference, 262; 95% con-
fidence interval, 245 to 279; P  0.0001), though median LVEF was higher in inferior MI (0.37+10 vs. 0.29+ 10;
P ¼ 0.0499).
Conclusion Patients included in defibrillator trials represent only a minority of the patients at risk of sudden cardiac death. By
applying the current risk stratification strategy based on LVEF, more than one third of the patients with old MI
would not have qualified for a prophylactic defibrillator. Our study also suggests that inferior scars may be more
prone to ventricular arrhythmia compared to anterior scars.
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Introduction
Ventricular tachyarrhythmias are responsible for most cases of
sudden cardiac death (SCD). Two common patterns in the
initiation of fatal arrhythmias have been recognized in coronary
artery disease (CAD), ventricular arrhythmia triggered by acute
ischaemia or infarction and ventricular arrhythmia related to an
anatomical substrate, usually scarring from a previous myocardial
infarction (MI).1 The relative incidence of these two mechanistic
pathways is uncertain and they constitute two poles of a conti-
nuum of pathophysiological scenarios. In a large proportion of
patients the interaction of ischaemia superimposed on a chronic
scar is probably responsible for the genesis of lethal arrhythmias
as demonstrated in numerous experimental studies.2– 4 The epide-
miological pattern of SCD is a major health care issue because of
its implications in helping profiling risk based on individual subject
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characteristics and for the efficient designs of clinical trials. Most
previous studies exploring the mechanistic pathways leading to
SCD were necropsy studies. To our knowledge, no unselected
large study integrated clinical characteristics and angiographic find-
ings to distinguish the patterns of life-threatening ventricular
arrhythmias in CAD. In particular, most studies defined SCD
without documentation of ventricular tachyarrhythmia and infor-
mation regarding myocardial areas of potential ischaemia was
limited. Most importantly, estimates of the left ventricular ejection
fraction (LVEF) could not be provided despite it is currently the
most widely used clinical determinant of risk after infarction and
has become the basis for determining a patient’s eligibility for pro-
phylactic implantable cardioverter defibrillator (ICD). The value of
prophylactic ICD has been established in patients with severely
reduced LVEF. It has however been suggested that these patients
may represent a minority of the total SCD.5 –7 The prospective
prophylactic ICD trials enrolled patients in the highest-risk sub-
groups because they yield event rates high enough to design
trials with a relatively limited number of patients. The Multicenter
Automatic Defibrillator Implantation Trial II (MADIT II) has shown
that patients with remote MI and advanced LV dysfunction benefit
from prophylactic ICD implantation.8 MADIT II was however a
study of very high-risk patients and outcomes hence address
highly specific segments of the population and represent relatively
small numbers. It is of the utmost importance for everyone
involved in developing and implementing strategies in primary pre-
vention of SCD to know the actual impact of these trials on the
general public health problem of sudden death.
The present study therefore aimed to determine the extent and
distribution of reduced LVEF in patients with documented life-
threatening ventricular arrhythmia related to CAD and the relative
incidence of the mechanistic pathways leading to the arrhythmic
event.
Methods
Patients and study protocol
Between January 1998 and April 2006, consecutive patients admitted
to our university-based hospital centre for sustained ventricular tachy-
cardia (VT) or ventricular fibrillation (VF) as first detected arrhythmia
were registered. Patients with documented ventricular arrhythmias
related to CAD occurring either out-of-hospital or upon admission
in the emergency room were included. Arrhythmic events occurring
in hospitalized patients or during coronary interventions were
excluded. The clinical, angiographic and echocardiographic data were
obtained during the index hospitalization. Eligibility was validated by
specifically reviewing the clinical records. Patients were classified
according to the presumptive mechanism by which CAD led to the
clinical arrhythmias.
The study protocol was in accordance with the ethical standard of
the Hospital Ethics Committee.
Angiography
The coronary arteries were divided into segments according to con-
ventional terminology.9 Proximal narrowings of large diagonal or mar-
ginal branches were considered as stenoses of the left anterior
descending or circumflex coronary arteries, respectively. Diseased
coronary artery was graded according to its narrowest stenosis as
not significant (,70%), significant (70–99%) or 100% obstruction.
Left main stem disease was considered if there was a .50% stenosis.
The number of significantly diseased coronary arteries was assigned
from 1 to 3. Hypokinetic or normal areas supplied by an artery with
a significant stenosis were considered to be areas of potential ischae-
mia. The LVEF was obtained from (in preferred order): a left ventricu-
logram, a radionuclide ventriculogram or an echocardiogram.
Myocardial infarction
The criteria for the diagnosis of acute MI was adapted from the report
of the American College of Cardiology Task Force on Clinical Data
Standards10 since patients may have died before blood samples for bio-
markers could be obtained (or in the lag phase before they could be
identified) and since episodes of VT or VF may be associated with a
modest elevation of cardiac enzymes (principally cardiac troponins)
due to metabolic demands exceeding supply, especially in patients
with CAD.11 For patients who survived the acute phase either of
the two following criteria met the diagnosis of acute MI: (1) typical
rise and fall of biochemical markers of myocardial necrosis
(CK-MB  2  the upper limit of normal) with at least one of the fol-
lowing: ischaemic symptoms prior to the arrhythmic event, develop-
ment of pathological Q waves on the ECG, ECG changes indicative
of ischaemia (ST-segment elevation or depression) or coronary
artery intervention; or (2) pathological findings of acute MI. For
patients who died before blood samples could be obtained, each fol-
lowing criteria met the diagnosis acute MI: presumably new ST
elevation, or new left-bundle branch-block and/or evidence of fresh
thrombi by coronary angiography and/or at autopsy.
The diagnosis of previous MI was based either on the clinical
records, the autopsy protocols, or the presence of a fixed defect on
thallium scanning or a localized akinesis or dyskinesis as determined
by left ventriculogram or echocardiogram with evidence of obstructive
CAD.
Statistical analysis
Quantitative parameters are given as arithmetic mean + SD for con-
tinuous variables and percentages for categorical variables. 95% CIs
for proportions and differences between categorical and continuous
variables were calculated. The x2 test was used to test differences
between proportions. The Student’s t-test was used for comparison
of continuous variables. Statistical significance was assumed for P,
0.05. Statistical analysis was performed using the software STATA,
version 8 (Stat Corp, College Station, TX, USA).
Results
Patients and relative incidence of the
mechanistic pathways leading
to ventricular arrhythmia
382 consecutive patients were admitted for documented sustained
VT or VF between January 1998 and April 2006. The study flow
diagram is shown in Figure 1. In 41 patients the cause of the
arrhythmia remained unknown either because of death without
autopsy or limited investigations due to poor prognosis. In 74
patients (22%), the underlying cause of ventricular arrhythmia
was not related to CAD.
Of the 267 patients with ventricular arrhythmia related to CAD
(78%), 15 patients with prior MI were excluded due to limited data,
either because of death on admission without autopsy or of limited
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investigations due to poor prognosis. The remaining 252 patients
were included in the study and classified in three groups according
to the presumptive mechanism of the clinical arrhythmia: 149
patients fulfilled the criteria of acute MI (¼ Group I, 59%); in the
103 patients with no evidence of acute MI, 54 had significant cor-
onary artery stenosis with areas of potential ischaemia as a possible
arrhythmic trigger (superimposed or not on a chronic scar) (¼
Group II, 21%) and 49 patients had a prior MI but no areas of
potential ischaemia according to angiography findings (¼ Group
III, 19%).
Clinical characteristics according to the
mechanism of arrhythmia
The clinical characteristics of patients according to the mechanistic
pathways leading to ventricular arrhythmia are presented in
Table 1. Mean age was 64+ 12 years and 79% were male.
Ventricular fibrillation accounted for the majority of first
recorded arrhythmias in Group I (VF and VT, 83 and 17%, respect-
ively; P, 0.0001). This proportion was reversed in Group III (VF
and VT, 35 and 65%, respectively; P ¼ 0.0006) whereas the preva-
lence of both arrhythmias was similar in patients Group II (54 and
46%, respectively; P ¼ 0.44). 52% of the patients presented with
out-of-hospital cardiac arrest. The prevalence of haemodynami-
cally stable and unstable VT did not significantly differ in Group
II (19 and 28%, respectively; P ¼ 0.25), while in Group III patients
presented more frequently with stable VT (47 and 18%, respect-
ively; P ¼ 0.003). In Group I, 23% of patients had a previous MI
whereas in Group II, transient ischaemia was superimposed on a
chronic MI scar in most cases (74% of cases). The time interval
between most recent MI and the arrhythmic event was known in
74% of the patients in Groups II and III and averaged 12.4+ 9.4
years (median 10.5, range 0–34). Ventricular tachyarrhythmia
was the first clinical manifestation of CAD in more than half of
the patients (54%) with the highest proportion in those with
acute MI (75% in Group I vs. 37 and 8% in Groups II and III,
respectively; P, 0.0001). Overall mean LVEF assessed after the
arrhythmic event was 36+ 12%. The proportion of patients with
an LVEF 40% was 46% in Group I, 40% in Group II and 33% in
Group III. As a whole, one third (34%) of the patients with
chronic MI who had experienced a ventricular arrhythmia not
related to acute MI had a LVEF 40%.
Data on LVEF evaluation performed within 5 years of the
arrhythmic event were available for 54 and 65% of the patients
in Groups II and III, respectively. The mean time interval
between the last LVEF assessment and the arrhythmic event was
15+17 months (median 6, range 0–57). Overall mean LVEF
was 39+12%. About one half of the patients had an LVEF
40% (52 and 50% in Groups II and III, respectively).
Patients that could have been identified to be at increased risk of
ventricular arrhythmia, i.e. with known CAD and evidence of an
old MI, represented 42% of the whole study population. Pre-event
LVEF was known for 63% of these patients and was 40% in half of
them (47%). Of the remaining patients, one quarter (26%) had an
LVEF 40% after the arrhythmic event. It can therefore be esti-
mated that no more than one quarter of the whole study popu-
lation had a known chronic MI with advanced LV systolic
dysfunction.
Angiographic data and infarct
characteristics according to the
mechanism of arrhythmia
The angiographic data and infarct characteristics according to the
mechanistic pathways leading to ventricular arrhythmia are pre-
sented in Table 2 (Group I) and Table 3 (Groups II and III). In
Figure 1 Study flow diagram of patients admitted for sustained ventricular tachycardia or ventricular fibrillation.
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acute MI, there was ST-segment elevation (1 mm in two or more
contiguous leads) in 80% of patients. The most frequent culprit
artery was the left anterior descending (49%) followed by the
right coronary artery (32%). There was a similar pattern of acute
and chronic MI localization in Groups I and II with a non-significant
trend towards more frequent anterior MI compared to inferior/
posterior MI (48 and 44% in Group I and 43 and 35% in Group
II; P ¼ 0.54 and 0.45, respectively). In Group III, a reversed
pattern was seen with statistically significantly more frequent
inferior/posterior MI compared to anterior MI (69 and 16%,
respectively; P, 0.0001). The infarct localizations are summarized
in Figure 2. In Groups II and III, about half of the patients had
chronic occluded coronary vessels with the right coronary artery
more often involved.
Characteristics of patients with an old
myocardial infarction and no residual
ischaemia (Group III)
Clinical and angiographic data of patients with anterior vs. inferior/
posterior scar and no residual ischaemia are presented in Table 4.
In patients with old MI as only arrhythmic substrate, inferior MI was
about four times more frequent compared to anterior MI. This
association was found despite a significantly better LVEF in inferior
MI compared to anterior MI (0.37+0.1 vs. 0.29+ 0.1, respect-
ively; P ¼ 0.0499). The proportion of VF vs. VT was similar in
both subgroups. There was a non-significant trend towards less
diffuse CAD and lower prevalence of chronic occlusion of the
infarct-related artery in patients with inferior MI. Unlike those
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Angiographic data and infarct characteristics
in patients with ventricular arrhythmias related to
acute MI (Group I)
Group I: acute MI
(n5 149)
ST-segment elevation MI (%) (95% CI) 80 (73–86)
Infarct-related artery (%) (95% CI)a
LAD 49 (40–58)
CX 13 (7–19)
RCA 32 (24–40)
Undetermined 6 (2–11)
Acute MI localization (%) (95% CI)
Anterior 48 (40–56)
Inferior/posterior 44 (36–52)
Lateral 4 (1–7)
Undetermined 4 (1–7)
One-vessel disease (%) (95% CI)a 43(34–52)
Chronic occlusion (bypass-vessel included) in a non-infarct-related
artery (%) (95% CI)a
no 82 (75–89)
LAD 2 (0–4)
LCX 6 (2–10)
RCA 10 (5–16)
Revascularization performed during
hospitalization (PCI or CABG) (%)
(95% CI)
71 (64–79)
aAngiographic data available for 84% of the patients in Group I.
CABG, coronary artery bypass graft; MI, myocardial infarction; PCI, percutaneous
coronary intervention.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Clinical characteristics of patients with
ischaemic heart disease according to the mechanistic
pathways leading to ventricular arrhythmia
Group I:
acute MI
(n 5 149)
Group II:
areas of
potential
ischaemia
as
ischaemic
trigger
(n 5 54)
Group III:
prior MI
no
residual
ischaemia
(n5 49)
Age (years) (mean+ SD) 61+13 68+11 68+10
Male sex (%) (95% CI) 79 (72–
85)
80 (69–91) 78 (65–90)
First recorded rhythm (%) (95% CI)
Ventricular fibrillation 83 (77–
89)
54 (40–67) 35 (21–49)
Unstable VT 11 (6–16) 28 (15–40) 18 (7–30)
Stable VT 6 (2–10) 19 (8–29) 47 (32–61)
Previous revascularization
(CABG or PCI) (%)
(95% CI)
11 (6–17) 31 (19–44) 61 (47–75)
Prior MI (%) (95% CI) 23 (16–
31)
74 (62–86) 100
Time elapsed since last MI
(years) (mean+ SD)a
6.7+5.4 12.8+10.9 12.3+8.3
Arrhythmia as first clinical
event of CAD (%)
(95% CI)
75 (68–
82)
37 (24–50) 8 (0–16)
LV ejection fraction evaluation before the arrhythmic eventb
Total (mean+ SD) – 39+14 38+11
,0.30 (%) (95% CI) 24 (8–41) 16 (2–29)
0.30–0.39 (%) (95% CI) 24 (8–41) 34 (17–52)
0.40 (%) (95% CI) 52 (32–71) 50 (32–68)
LV ejection fraction assessed after the arrhythmic eventc
Total (mean+ SD) 38+13 35+13 34+10
,0.30 (%) (95% CI) 26 (18–
35)
34 (21–47) 29 (15–42)
0.30–0.39 (%) (95% CI) 27 (19–
36)
26 (14–39) 39 (25–53)
0.40 (%) (95% CI) 46 (37–
56)
40 (26–53) 33 (19–46)
aData available for 50, 70 and 78% of the patients from Groups I, II, and III,
respectively.
bOnly evaluations performed within 5 years of the arrhythmic event considered.
Data available for 54% of the patients in Group II and 65% in Group III. Mean time
interval between the last LV ejection fraction evaluation and the arrhythmic event
15+ 17 months (median 6, range 0–57).
cData available for 75% of the patients in Group I and 100% in Groups II and III.
CABG, coronary artery bypass graft; CAD, coronary artery disease; LV, left
ventricular; MI, myocardial infarction; PCI, percutaneous coronary intervention;
VT, ventricular tachycardia.
P. Pascale et al.1642
 at Bibliotheque Cantonale et U
niversitaire on A
ugust 20, 2014
http://europace.oxfordjournals.org/
D
ow
nloaded from
 
with prior inferior MI, most patients with anterior MI had an LV
aneurysm (12 vs. 63%, respectively; P ¼ 0.0017).
Discussion
To the best of our knowledge, this is the single largest study to
date that has integrated clinical and angiographic characteristics
to evaluate the epidemiological pattern of ventricular arrhythmia
in CAD and bring into question the actual impact of recent pro-
phylactic ICD trials on the general health problem of SCD.
Relative incidence of the mechanistic
pathways leading to ventricular
arrhythmia
Acute MI was the most frequent mechanism leading to ventricular
arrhythmia representing 60% of cases, consistent with previous
necropsy series of sudden coronary death.12,13 About half of the
remaining cases had a chronic MI scar without residual ischaemia
and half had areas of potential transient ischaemia as possible
arrhythmic trigger. In the latter subgroup, a MI scar was found in
74% and the interaction of transient ischaemia superimposed on
chronic MI may have been responsible for the genesis of the
arrhythmic event as demonstrated in numerous experimental
studies.2– 4 Nevertheless, the proportion of patients in which tran-
sient ischaemia indeed led to the arrhythmic event cannot be
assessed.
Arrhythmia related to significant obstructive CAD potentially
leading to ischaemic episodes without acute or old MI, i.e.
‘purely’ ischaemic arrhythmia, represented only 6% of the whole
study group. Our findings hence tend to confirm that the response
to acute transient ischaemia on normal myocardium relatively
seldom leads to life-threatening arrhythmia compared with acute
ischaemia superimposed on acute, subacute or healed MI.2– 4
In patients with a myocardial scar as only arrhythmic substrate,
significant superimposed ischaemia was deemed extremely unlikely
based on the workup performed including angiography findings.
Whereas the proportion of healed MI in SCD has been extensively
studied, the proportion of patients with a myocardial scar as only
arrhythmic substrate, i.e. without associated areas of potential
ischaemia, has been only rarely evaluated. To our knowledge,
only two studies with a comparable methodology evaluated this
issue: in the chronic phase of MI, the proportions of patients
with no residual ischaemia were 44 and 67% compared to 55%
in the present study.14,15 Similarly, two stress-rest perfusion scinti-
graphic studies of survivors of SCD not related to acute MI
reported a proportion of patients with scar tissue alone of slightly
more than one half (55 and 58%, respectively) and scar tissue in
combination with ischaemic segments in the remaining cases.16,17
Left ventricular ejection fraction and
ventricular arrhythmia in the chronic
phase of MI
Despite the fact that LVEF is currently the most widely used clinical
determinant of risk after infarction and has become one of
the basis for determining a patient’s eligibility for prophylactic
ICD, we found that more than one third of the patients with
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Angiographic data and infarct characteristics
according to the mechanistic pathways leading to
ventricular arrhythmia in patients without evidence of
acute MI
Group II: areas of
potential
ischaemia as
ischaemic trigger
(n 5 54)
Group III: prior
MI no residual
ischaemia
(n5 49)
Prior MI localization (%) (95% CI)
Anterior 43 (26–59) 16 (6–27)
Inferior/posterior 35 (20–50) 69 (56–83)
Anterior and inferior/
posterior
23 (9–36) 14 (4–24)
One-vessel disease (%)
(95% CI)a
30 (17–42) 63 (49–77)
Chronic occlusion (bypass-vessel included) (%) (95% CI)a
no 46 (33–60) 45 (30–59)
LAD 19 (8–29) 12 (3–22)
LCX 9 (1–17) 18 (7–30)
RCA 35 (22–48) 39 (25–53)
Revascularization
performed during
hospitalization (PCI or
CABG) (%) (95% CI)
56 (42–69) 0
Aneurysm post-MI (%)
(95% CI)
10 (0–20) 22 (10–35)
aAngiographic data available for all patients in Groups II and III.
CABG, coronary artery bypass graft; MI, myocardial infarction; PCI, percutaneous
coronary intervention.
Figure 2 Acute and chronic myocardial infarction localization
according to the mechanistic pathways leading to ventricular
arrhythmia.
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life-threatening ventricular arrhythmias in the chronic phase of MI
have an LVEF 40%. These patients would hence not have quali-
fied for primary prevention ICD implantation according to current
guidelines. These data are even more compelling when one realizes
that the LVEF measurements were made early after resuscitation,
therefore likely underestimated because of the post-resuscitation
myocardial stunning. The available data on pre-event LVEF evalu-
ation suggested that almost half of the patients with prior MI had
an LVEF 40%. However, this data must be interpreted with
caution because of the time interval between LVEF assessment
and the arrhythmic event. Moreover, these data may not be repre-
sentative of the population at risk since patients whose arrhythmia
was the first clinical manifestation of CAD are probably under-
represented and, on the other hand, symptomatic patients with
greater severity of pre-existing CAD are more likely to have
LVEF evaluated. There is no doubt that patients with CAD and
depressed LVEF have a higher rate of SCD. However, LVEF is
poor at distinguishing patients who will die from arrhythmia from
those who will die of other cardiovascular causes.18,19 This is illus-
trated in the Multicenter Unsustained Tachycardia Trial (MUSTT)
where no significant differences in the per cent of deaths attributed
to arrhythmia were found in patients with LVEF ,30% vs. those
with LVEF 30–40%.20 Since the number of patients surviving the
acute phase of MI with less severely reduced LVEF is much
greater, they represent a significant proportion of the total
number of patients with SCD. In the Cardiac Arrhythmia Suppres-
sion Trial (CAST)21 60% of deaths were due to arrhythmias in
patients with LVEF 20–29% as well as in those with 30–39%.
However, 1.7 times as many patients had an LVEF of 30–39% as
had an LVEF 20–29%. Therefore, although the rate of death or
cardiac arrest was higher for patients with more depressed LVEF,
the greater number of patients with higher LVEF resulted in vir-
tually equal absolute numbers of cardiac arrests in both groups.
Accordingly, the highest-risk subgroups such as those studied in
the prospective prophylactic ICD trials may not account for the
majority of events in patients with CAD. Two studies previously
reported LVEF in SCD. The Oregon Sudden Unexpected Death
Study22 evaluated 80 subjects with CAD. The LVEF before SCD
was severely reduced in 34% of the patients, mildly to moderately
reduced in 30%, and normal in 36%. In a community-based study of
SCD in Maastricht, the Netherlands,23 among 200 cases of SCD
with previous assessment of LVEF, 51% had a normal LV function
and only 19% had an LVEF 30%. This study was however limited
to cases 20–75 years old and included all causes of SCD, yet more
than 70% of SCD were related to CAD.
Primary prevention of SCD requires the ability to identify indi-
vidual patients at risk from among population pools. However,
our study shows that ventricular arrhythmia is the first clinical
manifestation of CAD in about half of the patients consistent
with previous studies on SCD.13,24,25 Patients with known CAD
and evidence of a prior MI represented 42% of the whole study
group. Based on the available data on pre-event LVEF and the pro-
portion of patients with LVEF 40% after the arrhythmic event, it
can be estimated than no more than one quarter of the whole
study population would have been covered by the current guide-
lines for prophylactic ICD implantation.
Most previous studies on risk stratification and primary
prevention of SCD used relatively brief follow-up period, usually
2 years. Our study shows that the median interval between
most recent MI and the arrhythmic event was many years (10.5)
with a very wide variation. The later occurrence of ventricular
arrhythmia years after MI had also been observed in the
community-based study of SCD in Maastricht23 and was indirectly
suggested by the survival benefit of ICD in MADIT II that appeared
to be greater for remote MI and remained substantial for up to
15 years after MI.26 These findings raise the issue of how long
studies on risk stratification and primary prevention of SCD
should report follow-up to fully appraise the predictive value of
a risk factor or the survival benefit of ICD.
Importance of the infarct localization
While previous studies focused on the ‘quantitative’ issue of prior
MI characterization, the question whether a specific localization of
prior MI could be at higher risk of substrate-related arrhythmia has
to our knowledge not been addressed. We demonstrated an unex-
pected highly significant relation between inferior MI and
substrate-related arrhythmias that is even more compelling consid-
ering that LVEF was significantly higher after old inferior MI.
However, this relation applies only to patients with MI scars
without areas of potential ischaemia since in the setting of
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Table 4 Characteristics of patients with ventricular arrhythmia arising from chronic scar without superimposed
ischaemia (Group III) according to the localization of prior MI (n5 42)
Prior anterior
MI
Prior inferior/
posterior MI
Absolute
difference
P
Prior MI localization (%) (95% CI) 19 (7–31) 81 (69–93) 262 (245 to 279) <0.0001
Ventricular fibrillation as first recorded rhythm (%) (95% CI) 25 (0–55) 35 (19–51) 210 (þ24 to 244) 0.58
LVEF (mean + SD) (95% CI) 0.29+0.1 0.37+0.1 20.08 (20.16 to 0) 0.0499
Chronic occlusion of the infarct-related artery (bypass-vessel included) (%)
(95% CI)
75 (45–100) 50 (33–67) þ25 (29 to þ59) 0.20
No or one vessel disease (%) (95% CI) 88 (65–100) 65 (49–81) þ23 (25 to þ51) 0.21
Left ventricular aneurysm post-MI (%)(95% CI) 63 (29–96) 12 (1–23) þ51 (þ15 to þ86) 0.0017
LVEF, left ventricular ejection fraction; MI, myocardial infarction.
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superimposed ischaemia a similar proportion of prior anterior and
inferior MI was found. It is unlikely that this association was related
to a higher probability of return of spontaneous circulation in
patients with prior inferior compared to anterior MI. If this selec-
tion bias was relevant we would have expected similar findings in
patients with residual ischaemia and especially those with acute MI
and there was indeed a trend towards more frequent anterior MI
in these subgroups.
The mechanism underlying this apparent propensity of inferior
MI to suffer from substrate-related arrhythmia is unclear. Right
ventricular (RV) involvement may have contributed since it accom-
panies 30 to 50% of inferior wall MI. As the prevalence of ventri-
cular arrhythmias is related to infarct size, it could be an
unappreciated source of ventricular arrhythmias despite relatively
unaffected LVEF. There have been reports demonstrating that RV
involvement in inferior MI was associated with a higher risk of sus-
tained VT and VF despite similar LV infarct size and function.27
Similarly, patients with residual RV dysfunction after inferior MI
showed an increased risk of sudden death independent of
LVEF.28 An alternative explanation may pertain to the differences
in cardiac autonomic innervation. Experimental and clinical
studies have demonstrated that the electrical stability of the myo-
cardium depends in part on the balance between the two limbs of
the autonomic nervous system.29,30 Specifically, sympathetic
hyperactivity favours the onset of ventricular arrhythmia,
whereas vagal activation exerts a protective effect after healed
MI. A greater density of receptors with vagal afferents has been
demonstrated in the infero-posterior wall of the left ventricle as
exemplified by the enhanced vasodepressor and cardio-inhibitory
reflexes noted in response to inferior wall MI.31,32 Inferior wall
MI may hence damage the afferent traffic on vagal sensory
endings given their preferential distribution. This would displace
the entire range of protective vagal responses towards lower
values, thus increasing the risk of malignant arrhythmia. Some
observations consistent with this hypothesis suggested that the
ability to augment vagal activity was lower in patients with inferior
MI compared to anterior MI.33,34
Study limitations
Our study has several potential limitations. First, we included
patients admitted to the hospital, hence with initial return of spon-
taneous circulation, which may constitute a bias inherent to the
purpose of the study. Our findings may not reflect the character-
istics of the overall population with out-of-hospital ventricular
arrhythmias since patients who died before admission (or if resus-
citation was not attempted) had to be excluded. However, since
the single most important factor that determines the chances of
initial return of spontaneous circulation is access to prompt defi-
brillation rather than the patient’s characteristics,35 this selection
bias should not have a major influence on how representative
the study population is. This is illustrated by the absence of impor-
tant differences compared to previous studies that included unse-
lected patients with out-of-hospital SCD. Second, the diagnosis of
acute MI was mostly based on clinical criteria and on coronary
angiography performed in the majority of cases. The criteria
used took account of the fact that episodes of VT or VF may be
associated by a modest elevation of cardiac enzymes due to
metabolic demands exceeding supply. Nevertheless, it may be
possible that, in few cases, the arrhythmia was indeed related to
an acute MI with only transient active coronary lesions and/or
minimal consecutive myocardial damage. Similarly, the diagnosis
of prior MI was based on clinical records and imaging techniques
in the majority of cases. Necropsy was performed in a minority
of cases and imaging techniques with high resolution as cardiac
MRI was not performed. Accordingly, some previous silent MI
may not have been recognised. It must however be underlined
that the criteria used in the study were similar to those used in
general clinical practice for the identification of candidates for pro-
phylactic ICD.
Clinical implications
We demonstrated that patients included in recent prophylactic
ICD trials represent only a minority of those at risk of SCD.
Since current recommendations are largely based on these trials,
our findings challenge the adequacy of the actual primary preven-
tion strategy. Our study hence supports the conclusion that a risk
stratification strategy based only on the predictive power of
depressed LVEF applies to small subgroups and misses numerous
candidates for prophylactic ICD from general population pools.
Accordingly, future research efforts should not be restricted to
patients with depressed LVEF and new methods are warranted
to allow the identification of high-risk clusters within larger sub-
groups that have lesser degrees of increased risk.
According to current guidelines, aggressive attempts should be
made to treat myocardial ischaemia and evaluation of the need
for an ICD should be deferred after revascularization of accessible
coronary artery stenosis. We could demonstrate in this subset of
patients, i.e. with prior MI and no areas of potential ischaemia, a
highly significant relation between inferior MI and ventricular
arrhythmias. The hypothesis that inferior MI scars may be more
prone to electrical instability compared to anterior scars warrants
further investigations.
Conflict of interest: none declared.
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